MENLO PARK, Calif., Oct. 20, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare know-how firm targeted on creating modern options supposed to rework care and enhance sufferers’ lives, right this moment introduced it would report monetary outcomes for the third quarter ended September 30, 2022, after the market shut on Thursday, November 10, 2022. The firm’s administration will focus on the outcomes throughout a convention name starting at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Investors taken with listening to the convention name could accomplish that by accessing a stay and archived webcast of the occasion at www.sightsciences.com, on the Investors web page within the News & Events part. The webcast can be accessible for replay for at the very least 90 days after the occasion.
About Sight Sciences
Sight Sciences is an eyecare know-how firm targeted on growing and commercializing modern options supposed to rework care and enhance sufferers’ lives. Using minimally invasive or non-invasive approaches to goal the underlying causes of the world’s most prevalent eye illnesses, Sight Sciences seeks to create more practical therapy paradigms that improve affected person care and supplant typical outdated approaches. The Company’s OMNI® Surgical System is a minimally invasive glaucoma surgical procedure (MIGS) machine indicated to cut back intraocular strain in grownup sufferers with major open-angle glaucoma (POAG), the world’s main reason behind irreversible blindness. The SION™ Surgical Instrument is a bladeless, operated by hand machine utilized in ophthalmic surgical procedures to excise trabecular meshwork. The Company’s TearCare® System is 510(ok) cleared within the United States for the applying of localized warmth remedy in grownup sufferers with evaporative dry eye illness due to meibomian gland dysfunction (MGD), enabling office-based clearance of gland obstructions by physicians to tackle the main reason behind dry eye illness.
For extra info, go to www.sightsciences.com.
OMNI® and TearCare® are registered logos of Sight Sciences.
SION™ is a trademark of Sight Sciences.
© 2022 Sight Sciences. All rights reserved.
Investor contact:
Philip Taylor
Gilmartin Group
415.937.5406
[email protected]
